Skip to main content
. 2021 Oct 14;12:738316. doi: 10.3389/fphar.2021.738316

FIGURE 2.

FIGURE 2

Altered expression of T cell subsets in AS patients after treated with secukinumab. The proportion of T cell subsets measured by flow cytometry at baseline and after receiving secukinumab in AS patients. ns, not significant; *, p < 0.05; **, p < 0.01; ***, p ≤ 0.001; ****, p < 0.0001.